SCHEMBL2024390

SCHEMBL2024390

CN(C)S(=O)(=O)N[C@@H]1Cc2c(n(Cc3cccnc3N)c3ccc(C#N)cc23)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCARB1 Q8WTV0 3/20 0.39
▸ HTR6 P50406 2/20 0.36
▸ HRH1 P35367 1/20 0.36
▸ GUCY1A1 Q02108 1/20 0.32
▸ GUCY1B1 Q02153 1/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ FNTA P49354 2/20 0.32
▸ FNTB P49356 2/20 0.32
▸ NR1D1 P20393 1/20 0.31
▸ JAK2 O60674 1/20 0.31
▸ JAK1 P23458 1/20 0.31
▸ TYK2 P29597 1/20 0.31
▸ PTGDR2 Q9Y5Y4 1/20 0.31
▸ DDB1 Q16531 1/20 0.31
▸ CRBN Q96SW2 1/20 0.31
▸ GPR6 P46095 1/20 0.30
▸ PTK2 Q05397 1/20 0.30
▸ ICAM1 P05362 1/20 0.30
▸ VCAM1 P19320 1/20 0.30
▸ GRIA2 P42262 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2024391 1.00 SCARB1 (0.39) SCARB1HTR6HRH1GUCY1A1GUCY1B1
SCHEMBL14217997 0.89 ICAM1 (0.33) PTGDR2ICAM1VCAM1GRIA2
SCHEMBL2021412 0.86 HTR6 (0.47) SCARB1HTR6HRH1FNTAFNTB
SCHEMBL12579067 0.86 HTR6 (0.47) SCARB1HTR6HRH1FNTAFNTB
SCHEMBL2027983 0.86 HTR6 (0.47) SCARB1HTR6HRH1FNTAFNTB
SCHEMBL2027538 0.86 SCARB1 (0.36) SCARB1HTR6HRH1
SCHEMBL2022793 0.86 SCARB1 (0.36) SCARB1HTR6HRH1
SCHEMBL2024644 0.85 SCARB1 (0.40) SCARB1HTR6HRH1FNTAFNTB
SCHEMBL2024643 0.85 SCARB1 (0.40) SCARB1HTR6HRH1FNTAFNTB
SCHEMBL2021687 0.83 SCARB1 (0.41) SCARB1HTR6HRH1FNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2094658-B1 TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS LILLY CO ELI (US) 2011-12-21 — — EP disclosed
EP-2094658-B1 TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS LILLY CO ELI (US) 2011-12-21 — — EP disclosed
US-7968587-B2 Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators ELI LILLY AND COMPANY (US) 2011-06-28 — — US disclosed
US-7968587-B2 Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators ELI LILLY AND COMPANY (US) 2011-06-28 — — US disclosed
US-7968587-B2 Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators ELI LILLY AND COMPANY (US) 2011-06-28 — — US disclosed
US-20100069404-A1 TETRAHYDROCYCLOPENTA[b] INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS ELI LILLY AND COMPANY 2010-03-18 — — US disclosed
US-20100069404-A1 TETRAHYDROCYCLOPENTA[b] INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS ELI LILLY AND COMPANY 2010-03-18 — — US disclosed
US-20100069404-A1 TETRAHYDROCYCLOPENTA[b] INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS ELI LILLY AND COMPANY 2010-03-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069404-A1 TETRAHYDROCYCLOPENTA[b] INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS AR, NR5A1, MUSK SCARB1 1045/4885HTR6 251/4885HRH1 1313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback